PafusGuC: Benefit of Ultrasound Guidance in Arteriovenous Fistula (AVF) Cannulation in Pediatric Hemodialysis

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Recruiting
CT.gov ID
NCT05556915
Collaborator
(none)
20
1
2
30
0.7

Study Details

Study Description

Brief Summary

The arteriovenous fistula (AVF) is the reference hemodialysis vascular access for both adult and pediatric patients. The cannulation quality is decisive for the quality of the dialysis. Difficult AVF cannulations are more frequent in pediatrics than in adults. Recent studies in adults have shown that ultrasound-guided AVF cannulation improves the cannulation quality and therefore the quality of dialysis. This study aims to prove that ultrasound-guided AVF cannulation in children will improve the quality of dialysis overall.

Condition or Disease Intervention/Treatment Phase
  • Other: Ultrasound-guided AVF cannulation method
  • Other: Conventional AVF cannulation method
N/A

Detailed Description

The European and American recommandations emphasize that the arteriovenous fistula (AVF) is the first choice vascular access in hemodialysis for both adult and pediatric patients. Indeed, infections and thrombotic complications are lower with an AVF than with a central venous catheter. In addition, the efficiency of dialysis is better in patients with AVF in both pediatric and adult patients.

The pediatric population has its own characteristics. On the one hand, the size of the vessels, in particular in patients weighing less than 20 kilos, complicates the creation of the AVF. On the other hand, the time for AVF maturation in children (corresponding to the time required between the creation of the AVF and its use) is much higher than that of the adult population. These specific anatomical characteristics partly explain the more frequent AVF cannulation difficulties in pediatric patients.

Inadequate dialysis is considered to be a session in which the therapy goals were not achieved. This rate of inadequate dialysis is estimated at 8-10% in children due to vascular access problem, whereas this rate is only 1 to 5% in adults. There is also an increase in side effects related to these pediatric AVF cannulation difficulties (trauma, hematoma, edema following diffusion, etc.) responsible for inadequate dialysis and, in the long term, AVF dysfunction (stenosis, thrombosis).

The preservation of the vascular access by means of new cannulation techniques aimed at limiting trauma is therefore a primary objective in pediatric hemodialysis. The introduction of new cannulation methods as well as the training of nurses/childcare workers in the various puncture techniques would thus make it possible to improve the quality of dialysis sessions, the lifespan of AVFs, to increase the number of puncture sites and reduce the number of punctures per session and the occurrence of complications.

Recently, the ultrasound-guided AVF cannulation technique has shown promising results in adults with regard to the prevention of vascular access complications, the feeling of pain and the obtaining of adequate dialysis.

A recent review points to the need to confirm the benefit of ultrasound-guided cannulation through randomized studies, the current data being promising but needing to be confirmed. To date, no data concerning the benefit of ultrasound-guided cannulation in pediatrics is available in the literature. Our project will therefore be the first research to compare 2 AVF cannulation methods in pediatric hemodialysis. The hypothesis adopted is that the AVF cannulation using ultrasound guidance in children undergoing dialysis will allow an overall improvement of dialysis quality, a reduction of complication occurrence and an improvement of patient comfort.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Open label, randomized clinical study comparing two AVF cannulation methodes (conventional vs ultrasound-guided method) in pediatric patients with end-stage renal disease undergoing hemodialysis therapy.Open label, randomized clinical study comparing two AVF cannulation methodes (conventional vs ultrasound-guided method) in pediatric patients with end-stage renal disease undergoing hemodialysis therapy.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Intérêt de l'échoguidage Dans Les Ponctions de Fistule artério-veineuse en hémodialyse pédiatrique
Actual Study Start Date :
Dec 3, 2022
Anticipated Primary Completion Date :
Jun 3, 2025
Anticipated Study Completion Date :
Jun 3, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ultrasound-guided AVF cannulation method

The AVF cannulation is carried out using ultrasoud guidance

Other: Ultrasound-guided AVF cannulation method
For ultrasound-guided cannulation, the same ultrasound device will be used for all patients (TE5-POC ultrasound MINDRAY® system). The ultrasound device will identify the AVF aspect , the location including the depth (distance from the skin surface) , the vessel diameter and guide the cannulation in real-time. The device will be disinfected between uses and covered with a transparent adhesive film to avoid any direct contact with the patient. Sterile gel will be used for the cannulation.

Other: Conventional AVF cannulation method

The AVF cannulation is carried out by palpation

Other: Conventional AVF cannulation method
The AVF cannulation is carried out by palpation. This technique consists of manually evaluating the position, direction and depth of the fistula in order to determine the puncture site where the 2-dialysis catheters will be inserted. After local asepsis, the AVF is therefore needled at 2 points 5 cm apart.

Outcome Measures

Primary Outcome Measures

  1. Compare the rate of inadequate dialysis after ultrasound-guided AVF cannulation vs. conventional cannulation in pediatric patients (<18 years) with end-stage renal disease undergoing hemodialysis therapy. [12 months]

    Inadequate dialysis is defined by the presence of one of the following parameters: Blood flow rate (BFR expressed in ml/min corresponding to the volume of blood in milliliters that flows per minute) less than 80% of adequate blood flow corresponding to a flow ≥ 7 ml per kilograms of weight with a maximum of 300 ml/min Requirement of single-needle dialysis after 3 cannulation failures Early discontinuation of hemodialysis Loss of dialysis circuit during the session Out of range arterial or venous pressure during dialysis requiring a drop in blood flow rate Purification coefficient defined by Kt/V <1.2: K represents the dialyzer clearance of urea (expressed in milliliters/ min and corresponds to the volume of blood in ml cleared of urea per minute ) // t (in minutes) represents the dialysis time duration // V (in milliliters) represents the volume of distribution of urea, and equals the patient's total body water

Secondary Outcome Measures

  1. Number of cannulations required for the insertion of the 2 dialysis catheters [During procedure]

    Compare the number of cannulations required for the insertion of the 2 dialysis catheters in conventional method vs ultrasound-guided method

  2. The time required for the insertion of the 2 catheters [During procedure]

    Compare the time required for the insertion of the 2 catheters in conventional method vs ultrasound-guided method

  3. The occurrence of cannulation complications [During procedure]

    Compare the occurrence of cannulation complications (hematoma, diffusion, aneurysm, etc.) in conventional method vs ultrasound-guided method

  4. The occurrence of dialysis incidents caused by catheters dysfunction [During procedure]

    Compare the occurrence of dialysis incidents caused by catheters dysfunction (decrease in dialysis flow, single-puncture dialysis, shortening of dialysis time, loss of circuit) in conventional method vs ultrasound-guided method

  5. Patient satisfaction [30 days, 90 days, 180 days and 12 months after enrollment]

    Compare the patient satisfaction in conventional method vs ultrasound-guided method using a satisfaction questionnaire

  6. Patient comfort [During the procedure]

    Compare the patient comfort in conventional method vs ultrasound-guided method. The visual analogue scale (VAS) will be used by patients > 5 years of age. The VAS measures from 0 to 10 the intensity of pain. The higher the score the less comfortable the procedure

  7. Patient comfort [During the procedure]

    Compare the patient comfort in conventional method vs ultrasound-guided method. The neonatal pain and discomfort scale (EDIN Échelle Douleur Inconfort Nouveau-Né ) will be used by patients ≤ 5 years of age. The EDIN scale uses five behavioural indicators of pain: facial activity, body movements, quality of sleep, quality of contact with nurses, and consolability. The scale measures friom 0 to 15 the intensity of pain. The higher the score the less comfortable the procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pediatric patients ˂ 18 years of age at enrollment

  • Patients with end-stage renal disease undergoing hemodialysis therapy

  • Patients carrying an arteriovenous fistula created more than 6 weeks before enrollment

  • Prior agreement of the patient and their legal representative by signing the parent's informed consent form

  • Patients affiliated to social security system

Exclusion Criteria:
  • Non-matured arteriovenous fistula according to the referring pediatrician

  • Patients undergoing dialysis at least partly through a central venous catheter

  • Estimated duration of dialysis less than 1 month in the investigation center

  • Participation in other intervention research

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uh Montpellier Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: Jean Philippe BOUDET, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT05556915
Other Study ID Numbers:
  • RECHMPL21_0526
First Posted:
Sep 27, 2022
Last Update Posted:
Dec 23, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2022